WO2024047508 - PHARMACEUTICAL COMPOSITIONS FOR HERPES VIRUS
National phase entry:
Publication Number
WO/2024/047508
Publication Date
07.03.2024
International Application No.
PCT/IB2023/058488
International Filing Date
28.08.2023
Title **
[English]
PHARMACEUTICAL COMPOSITIONS FOR HERPES VIRUS
[French]
COMPOSITIONS PHARMACEUTIQUES CONTRE LE VIRUS DE L'HERPÈS
Applicants **
ASSEMBLY BIOSCIENCES, INC.
Inventors
ZONG, Zhixin
WHITE, Nicole
WU, Yi
Priority Data
63/373,774
29.08.2022
US
63/484,838
14.02.2023
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3047 | |
| EPO | Filing, Examination, Granting | 17497 | |
| Japan | Filing, Examination, Granting | 2587 | |
| South Korea | Filing, Examination, Granting | 2984 | |
| USA | Filing, Examination, Granting | 6990 |
Total:
33,105
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present invention relates to methods and compositions for treating and/or inhibiting the development or progression of diseases or disorders caused by, or associated with, herpes virus infection. In particular, provided are long-acting injectable depot pharmaceutical compositions comprising a helicase-primase inhibitor; methods for their manufacture; and the use of said pharmaceutical compositions as a medicament and for the treatment of diseases or disorders caused by, or associated with, herpes virus.[French]
La présente invention concerne des méthodes et des compositions pour le traitement et/ou l'inhibition du développement ou de la progression de maladies ou de troubles provoqués par une infection par le virus de l'herpès ou associés à celle-ci. En particulier, l'invention concerne des compositions pharmaceutiques injectables à effet retard et à action prolongée comprenant un inhibiteur de l'hélicase primase; leurs procédés de fabrication; et l'utilisation desdites compositions pharmaceutiques en tant que médicament et pour le traitement de maladies ou de troubles provoqués par le virus de l'herpès ou associés à celui-ci.